tiprankstipranks
Vasamed Inc (VSMD)
OTHER OTC:VSMD
US Market

Vasamed (VSMD) Price & Analysis

3 Followers

VSMD Stock Chart & Stats

$0.04
$0.00(0.00%)
At close: 4:00 PM EDT
$0.04
$0.00(0.00%)

VSMD FAQ

What was Vasamed Inc’s price range in the past 12 months?
Vasamed Inc lowest stock price was $0.04 and its highest was $0.04 in the past 12 months.
    What is Vasamed Inc’s market cap?
    Vasamed Inc’s market cap is $8.00.
      When is Vasamed Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Vasamed Inc’s earnings last quarter?
      Currently, no data Available
      Is Vasamed Inc overvalued?
      According to Wall Street analysts Vasamed Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Vasamed Inc pay dividends?
        Vasamed Inc does not currently pay dividends.
        What is Vasamed Inc’s EPS estimate?
        Vasamed Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Vasamed Inc have?
        Vasamed Inc has 8,011,000 shares outstanding.
          What happened to Vasamed Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Vasamed Inc?
          Currently, no hedge funds are holding shares in VSMD
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Vasamed Inc

            Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
            Similar Stocks
            Company
            Price & Change
            Follow
            Retractable Technologies
            Milestone Scientific
            GlucoTrack
            Sanara MedTech

            Ownership Overview

            0.61%99.39%
            Insiders
            Mutual Funds
            0.61% Other Institutional Investors
            99.39% Public Companies and
            Individual Investors
            Popular Stocks